Washington Federal health regulators said Monday the drugmaker Pfizer has agreed to pull a leukemia drug off the market after a follow-up study showed it failed to slow the disease. The Food and Drug Administration (FDA) cleared the drug Mylotarg in 2000 under its accelerated approval program, which grants speedy access to drugs that show early promise. The drug was cleared for patients older ...